Log In
Print this Print this

Ultram ER, tramadol

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionExtended-release mu opioid receptor (MOR) agonist
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat pain associated with osteoarthritis (OA); Treat severe chronic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today